Found 112 clinical trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
- 102 views
- 08 Nov, 2020
- 1 location
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension
- 552 views
- 25 Mar, 2021
- 1 location
Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
the cardiac myocardium. Beta-blockers can antagonize the effects of catecholamine. In patients with VA-ECMO, the protective effect of beta-blocker may improve the patients' outcome. This hypothesis
- 0 views
- 23 Jan, 2021
- 1 location
Pragmatic Trial of Messaging to Providers About Treatment of Heart Failure
A randomized controlled trial to compare the efficacy of an electronic health record-based alert informing providers about evidence-based medications for HFrEF versus usual care (no alert) in outpatient clinics across a single health system.
- 0 views
- 22 Mar, 2021
- 1 location
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis
Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis
- 0 views
- 30 Jan, 2021
- 1 location
Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
The major clinical problems in patients with Marfan Syndrome (MFS) are aortic root dilation (ARD), dissection and rupture. Although the available treatments (beta-blockers, BBs) improve
- 160 views
- 07 Nov, 2020
- 1 location
Anakinra Versus Placebo for the Treatment of Acute MyocarditIS
> Hypothesis : ANAKINRA in addition to standard therapy for treatment of Acute Myocarditis is superior to standard therapy based on an association of beta-blockers and Angiotensin-Converting-Enzyme
- 1 views
- 27 Jan, 2021
- 3 locations
Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine
), with an elevated heart rate (sinus rhythm with HR ≥ 90 bpm) and contraindications to beta-blockers (BBs). Treatment period will last 4 days. All patients will be followed for up to six months.
- 2 views
- 08 Nov, 2020
- 1 location
Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients
months using an electronic pill. The antihypertensive treatments considered for the study belong to the following classes: diuretics, beta-blockers, calcium-blockers, ACE (angiotensin-converting enzyme
- 0 views
- 23 Jan, 2021
- 2 locations
Effect of Midodrine on HVPG in Advanced Chronic Liver Disease
is decreased by midodrine, then it can be used in place of beta blockers when they are contraindicated or have the potential of causing adverse effects.
- 0 views
- 09 Apr, 2021
- 1 location